Company intelligence / Profile preview

Perimeter Medical Imaging AI

Toronto, Ontario, Canadaperimetermed.com ↗

Ownership: Private
Development stage: Commercial

Overview

The FDA-cleared S-Series OCT system enables real-time, high-resolution visualization of excised tissue margins during surgery. The investigational B-Series OCT with ImgAssist AI has demonstrated a sensitivity of up to ~96.8% in identifying positive breast cancer margins in retrospective studies and is currently being evaluated in a pivotal clinical trial to assess its impact on re-operation rates for breast-conserving surgery patients.

Therapeutic areas: Oncology
Modalities: DeviceArtificial intelligence software (clinical decision support)
Industry: Medical Imaging

Partnerships

Cancer Prevention and Research Institute of Texas (CPRIT) – grant funding partner for ATLAS AI project/B-Series development

Beyond the preview

Go deeper on Perimeter Medical Imaging AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perimeter Medical Imaging AI.

Explore the full profile